Space Exploration Technologies Corp. - Class A Common Stock (SPCX)

Does the market's biggest-ever debut look like a bargain yet?

SpaceX is headed for some huge revenue growth over the next year.

Investors were expecting OpenAI to launch an IPO this year.

The space company has a long way to go to dethrone Nvidia.

If this catches on, one-hour deliveries from China could become a reality.

SpaceX dominates space, but investors may be missing the bigger question: which second-source stock becomes too important to ignore?

Recent weakness in the market's hottest tickers has many investors suddenly rethinking everything.

For SpaceX, acquiring AI coding start-up Cursor was another step on the road to becoming an end-to-end AI company.

SpaceX just raised a huge sum of money, but it won't last long if history is any guide.

SpaceX's Starfall test flight highlights a potentially massive future market in military logistics and orbital manufacturing, but it doesn't resolve the debate over the stock's valuation.

The list of ETFs holding SpaceX stock grows by the day, offering investors compelling options for indirect ownership.

SpaceX shares have fallen after a fast start.

Look for more than excitement to grow your money.

After falling roughly 25% this week, Rocket Lab stock is now off 44% from its high.

Altimetry Research values SpaceX at $1.3 to $1.5 trillion and sees balanced risk, while favoring ASML, Northrop Grumman, and GE Vernova as cleaner plays on AI and space infrastructure.

When things seem too good to be true on Wall Street, they typically are.

This cohort is linked by one common theme.

Despite SpaceX's growth, it may struggle to outpace the more successful consumer stocks.

There's a clear answer for today, but a murky one for the future.

This is one more step for the business to expand into robotics and AI.

Two major indexes are adding SpaceX stock. And when an index adds a stock, the funds that track it have to buy -- profitable or not.

Intel's comeback story is getting real. See what's driving the rally, what Foundry still must prove, and whether this AI bet makes the stock worth a second look.

Parabilis Medicines is ambitious, but it has Regeneron on its side already.

SpaceX's Starship megarocket is critical to future launches.

The deal adds a missing piece to the company's vertically integrated model at the software application layer.